BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29797253)

  • 1. Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC.
    Walker BA
    Methods Mol Biol; 2018; 1792():71-95. PubMed ID: 29797253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of MYC translocations in multiple myeloma cell lines.
    Dib A; Gabrea A; Glebov OK; Bergsagel PL; Kuehl WM
    J Natl Cancer Inst Monogr; 2008; (39):25-31. PubMed ID: 18647998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
    Gabrea A; Martelli ML; Qi Y; Roschke A; Barlogie B; Shaughnessy JD; Sawyer JR; Kuehl WM
    Genes Chromosomes Cancer; 2008 Jul; 47(7):573-90. PubMed ID: 18381641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
    Chesi M; Kuehl WM; Bergsagel PL
    Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
    Shou Y; Martelli ML; Gabrea A; Qi Y; Brents LA; Roschke A; Dewald G; Kirsch IR; Bergsagel PL; Kuehl WM
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):228-33. PubMed ID: 10618400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
    Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
    Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
    Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
    Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.
    Affer M; Chesi M; Chen WG; Keats JJ; Demchenko YN; Roschke AV; Van Wier S; Fonseca R; Bergsagel PL; Kuehl WM
    Leukemia; 2014 Aug; 28(8):1725-1735. PubMed ID: 24518206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microhomology-mediated end joining drives complex rearrangements and overexpression of
    Mikulasova A; Ashby C; Tytarenko RG; Qu P; Rosenthal A; Dent JA; Ryan KR; Bauer MA; Wardell CP; Hoering A; Mavrommatis K; Trotter M; Deshpande S; Yaccoby S; Tian E; Keats J; Auclair D; Jackson GH; Davies FE; Thakurta A; Morgan GJ; Walker BA
    Haematologica; 2020 Apr; 105(4):1055-1066. PubMed ID: 31221783
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular genetic methods for the prognostic criteria in multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2005 Aug; 146(32):1673-82. PubMed ID: 16149245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.
    Valera A; Balagué O; Colomo L; Martínez A; Delabie J; Taddesse-Heath L; Jaffe ES; Campo E
    Am J Surg Pathol; 2010 Nov; 34(11):1686-94. PubMed ID: 20962620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
    Barwick BG; Neri P; Bahlis NJ; Nooka AK; Dhodapkar MV; Jaye DL; Hofmeister CC; Kaufman JL; Gupta VA; Auclair D; Keats JJ; Lonial S; Vertino PM; Boise LH
    Nat Commun; 2019 Apr; 10(1):1911. PubMed ID: 31015454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
    Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
    J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
    Avet-Loiseau H; Brigaudeau C; Morineau N; Talmant P; Laï JL; Daviet A; Li JY; Praloran V; Rapp MJ; Harousseau JL; Facon T; Bataille R
    Genes Chromosomes Cancer; 1999 Jan; 24(1):9-15. PubMed ID: 9892103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal and genetic abnormalities in myeloma.
    Joy Ho P
    Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
    Smadbeck J; Peterson JF; Pearce KE; Pitel BA; Figueroa AL; Timm M; Jevremovic D; Shi M; Stewart AK; Braggio E; Riggs DL; Bergsagel PL; Vasmatzis G; Kearney HM; Hoppman NL; Ketterling RP; Kumar S; Rajkumar SV; Greipp PT; Baughn LB
    Blood Cancer J; 2019 Dec; 9(12):103. PubMed ID: 31844041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein.
    Iida S; Hanamura I; Suzuki T; Kamiya T; Kato M; Hayami Y; Miura K; Harada S; Tsuboi K; Wakita A; Akano Y; Taniwaki M; Nitta M; Ueda R
    Int J Hematol; 2000 Jul; 72(1):85-91. PubMed ID: 10979215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex IGH rearrangements in multiple myeloma: Frequent detection discrepancies among three different probe sets.
    Kim GY; Gabrea A; Demchenko YN; Bergsagel L; Roschke AV; Kuehl WM
    Genes Chromosomes Cancer; 2014 Jun; 53(6):467-74. PubMed ID: 24585545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.